cytarabine and Autosomal Dominant Cerebellar Ataxia, Type II

cytarabine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Honda, M; Nakano, T; Ono, H; Tanabe, M	1

Other Studies

1 other study(ies) available for cytarabine and Autosomal Dominant Cerebellar Ataxia, Type II

Article	Year
Glycine transporter blockade ameliorates motor ataxia in a mouse model of spinocerebellar atrophy. Journal of pharmacological sciences, 2009, Volume: 109, Issue:3 Topics: Animals; Binding Sites; Cytarabine; Disease Models, Animal; Dose-Response Relationship, Drug; Glycine; Glycine Plasma Membrane Transport Proteins; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Receptors, N-Methyl-D-Aspartate; Sarcosine; Serine; Spinocerebellar Ataxias	2009

Article

Year

Glycine transporter blockade ameliorates motor ataxia in a mouse model of spinocerebellar atrophy.

Journal of pharmacological sciences, 2009, Volume: 109, Issue:3

Topics: Animals; Binding Sites; Cytarabine; Disease Models, Animal; Dose-Response Relationship, Drug; Glycine; Glycine Plasma Membrane Transport Proteins; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Receptors, N-Methyl-D-Aspartate; Sarcosine; Serine; Spinocerebellar Ataxias

2009